December 9, 2011
Science examines recent successes in clinical trials in the HIV prevention field, limitations to mathematical models resulting from these trials, and funding issues facing campaigns to ramp up HIV prevention interventions. "[M]odels now suggest that combining [prevention strategies] might virtually stop HIV's spread," but "there's a vast difference between a study having success and thwarting HIV in the real world," according to Science. "Models only point out routes to ending AIDS, and many will surely differ," the magazine writes, concluding, "But for the first time since AIDS surfaced 31 years ago, many researchers believe the destination itself is no longer a mirage" (Cohen, 12/9).
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.